Prostate cancer trials in Spain

In Spain 102 Also abroad 1481

102 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
Where
Barcelona, Córdoba, Madrid, Málaga, Sevilla
Age
18 years to 130 years
People
454 worldwide
Run by
AstraZeneca
See details and how to joinNCT05489211 · EU 2023-509436-26-00
Phase 1Taking people
Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
Where
Barcelona, Madrid
Age
18 years to 100 years
People
116 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07006727 · EU 2024-519111-34-00
Phase 1Taking people
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Where
Barcelona, Madrid, Piqueras, Seville
Age
18 years and over
People
540 worldwide
Run by
SystImmune Inc.
See details and how to joinNCT05983432
Phase 3Taking people
Phase 3 Study of Xaluritamig Plus Abiraterone vs Investigator's Choice in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Where
A Coruña, Barcelona, Jerez de la Frontera, L'Hospitalet de Llobregat, Lugo, Madrid, Majadahonda, Málaga, Pamplona
Age
18 years and over
People
297 worldwide
Run by
Amgen Inc.
See details and how to join2025-520555-89-00 · EU 2025-520555-89-00
No phaseTaking people
Daily Adaptive Radiation Therapy Using an Individualized Approach for Prostate Cancer
Where
Pamplona
Age
18 years and over
People
132 worldwide
Run by
Varian, a Siemens Healthineers Company
See details and how to joinNCT05804318
Phase 3Taking people
[18F]PSMA-1007 PET CT in patients with newly-diagnosed prostate cancer
Where
Barcelona, Valencia
Age
18 years and over
People
355 worldwide
Run by
Abx Advanced Biochemical Compounds - Biomedizinische Forschungsreagenzien GmbH
See details and how to join2023-504026-19-01 · EU 2023-504026-19-01
Phase 2Taking people
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
Where
Barcelona, L'Hospitalet de Llobregat, Madrid, Santiago de Compostela
Age
18 years and over
People
218 worldwide
Run by
Astellas Pharma Global Development, Inc.
See details and how to joinNCT07005154 · EU 2024-517653-27-00
Phase 1Taking people
Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies
Where
Barcelona, Córdoba, Girona, L'Hospitalet de Llobregat, Logrono, Madrid, Málaga, Pamplona, Pozuelo de Alarcón, Sevilla, Valencia
Age
18 years and over
People
180 worldwide
Run by
Duke Street Bio Ltd
See details and how to joinNCT06458712 · EU 2023-508805-26-00
Phase 1/2Taking people
A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate Cancer
Where
Barcelona, L'Hospitalet de Llobregat, Madrid
Age
18 years and over
People
52 worldwide
Run by
AstraZeneca
See details and how to joinNCT07192614 · EU 2025-520626-37-00
Phase 1Taking people
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Where
Barcelona, Madrid, Pamplona
Age
18 years and over
People
479 worldwide
Run by
Amgen
See details and how to joinNCT04221542 · EU 2023-504361-23-00
Phase 1/2Taking people
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Where
Barcelona, Girona, Madrid, Majadahonda, Palma, Pamplona, Pozuelo de Alarcón, Sabadell, Salamanca, Santiago de Compostela, Sevilla, Valencia
Age
18 years and over
People
300 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT04104776 · EU 2023-508002-20-00
Phase 3Taking people
Study Evaluating the Efficacy and Safety of Darolutamide and Stereotactic Dose Escalated Radiotherapy in Patients With Localized Prostate Cancer and High-risk Features of Relapse
Where
Badalona, Barcelona, Madrid, Valencia
Age
18 years to 80 years
People
700 worldwide
Run by
UNICANCER
See details and how to joinNCT06625970 · EU 2023-509787-15-00
Phase 1Taking people
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
Where
Barcelona, Madrid
Age
18 years and over
People
220 worldwide
Run by
MOMA Therapeutics
See details and how to joinNCT06545942
Phase 2Not yet taking people in Spain
Radium-223 for High-Volume Metastatic Hormone Sensitive Prostate Cancer
Where
Barcelona, Las Palmas de Gran Canaria, Madrid, Oviedo, Santander, Santiago de Compostela, Valencia, Valladolid
Age
18 years and over
People
50
Run by
Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD
See details and how to joinNCT07717099 · EU 2026-525550-11-00
Phase 2Taking people
Fractionated Stereotactic Radiotherapy Plus Second-generation Antiandrogen for Oligometastatic Castration-resistant Prostate Cancer Patients.
Where
Barakaldo, Barcelona, Bilbao, L'Hospitalet de Llobregat, Madrid, Oviedo, Pamplona, Salamanca, Santiago de Compostela, Terrassa, Valencia, Valladolid, Zaragoza
People
51
Run by
Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic
See details and how to joinNCT07717268
Phase 2/3Taking people
Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers (THUNDER): A Two-part Phase 2/3 Trial
Where
Barcelona, Madrid, Málaga, Valencia
Age
18 years and over
People
493 worldwide
Run by
Ziekenhuis Aan De Stroom
See details and how to join2022-501551-90-00 · EU 2022-501551-90-00
No phaseEnrolling by invitation
Evaluation of Pelvic Floor Function and Psychosocial Sequelae Following Radical Prostatectomy for Prostate Cancer
Where
Valencia
Age
18 years and over
People
67
Run by
University of Valencia
See details and how to joinNCT07693647
Phase 1Taking people
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
Where
Barcelona, Pozuelo de Alarcón
Age
18 years and over
People
275 worldwide
Run by
ORIC Pharmaceuticals
See details and how to joinNCT05413421 · EU 2024-515527-11-00
Phase 2Taking people
A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
Where
Madrid
Age
18 years and over
People
37 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT04641247 · EU 2023-506618-29-00
Phase 3Taking people
Phase III Randomized International Open Label Clinical Trial of Treatment Intensification With Docetaxel Plus Apalutamide in Patients With Metastatic Hormone-sensitive Prostate Cancer Who Did Not Achieve a Deep PSA Response After Initial Treatment With Apalutamide: REINFORCE Trial.
Where
Badalona, Barcelona, Granada, Las Palmas de Gran Canaria, L'Hospitalet de Llobregat, Madrid, Málaga, Murcia, Oviedo, Santander, Santiago de Compostela, Sevilla, Valencia, Valladolid, Zaragoza
Age
18 years and over
People
320 worldwide
Run by
Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD
See details and how to joinNCT07333066 · EU 2025-524408-30-01
Phase 2Taking people
SAKK 08/23: Addition of Darolutamide to first line treatment of mCRPC: a randomized open label phase II trial
Where
Barakaldo, Barcelona, Cáceres, Castello De La Plana, Córdoba, Lugo, Madrid, Oviedo, Palma, Pamplona, Sabadell, Salamanca, San Sebastián de los Reyes, Sevilla, Toledo, Valencia, Valladolid
Age
18 years and over
People
100
Run by
Swiss Group for Clinical Cancer Research
See details and how to join2024-512132-29-00 · EU 2024-512132-29-00
Phase 4Taking people
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
Where
Barcelona, L'hospitalet De Llobregat, L'Hospitalet de Llobregat, Madrid, Majadahonda, Málaga, Pamplona, Sabadell, Sevilla, Valencia
Age
18 years to 100 years
People
700 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT05803941 · EU 2023-503208-94-00
Phase 1/2Taking people
A Clinical Trial Evaluating the Safety of TD001 In Patients With PSMA-Expressing Metastatic Prostate Cancer
Where
Barcelona
Age
18 years and over
People
180 worldwide
Run by
T.O.A.D. Oncology SA
See details and how to joinNCT07258407 · EU 2025-523273-41-00
No phaseTaking people
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
Where
Badalona, Barcelona, Castellon, Madrid, Málaga, Oviedo, Valencia, Zaragoza
Age
21 years and over
People
5,000 worldwide
Run by
Prostate Cancer Clinical Trials Consortium
See details and how to joinNCT03151629
Phase 2Taking people
A basket study to investigate the efficacy and safety of SKB264 in combination with pembrolizumab in subjects with solid tumors
Where
Barcelona, Madrid, Santiago de Compostela, Sevilla, Valencia
Age
18 years and over
People
101 worldwide
Run by
Sichuan Kelun-Biotech Biopharmaceutical Co. Ltd.
See details and how to joinNCT05642780 · EU 2022-502654-14-00